Augmented interleukin-1β-induced depression of locomotor activity in cholestatic rats

Hepatology

Volumn 28, Issue 6, 1998, Pages 1561-1565

  Swain, Mark G ^a   Beck, Paul ^a   Rious, Kevin ^a   Le, Tai ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIA; ARTICLE; BILIARY TRACT SURGERY; CHOLESTASIS; CONTROLLED STUDY; CYTOKINE RELEASE; FATIGUE; ILLNESS BEHAVIOR; LETHARGY; LOCOMOTION; MALAISE; MALE; MORBIDITY; NONHUMAN; PATHOGENESIS; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; RAT; ANIMAL; ANIMAL BEHAVIOR; DRUG EFFECT; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PATIENT ATTITUDE; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; SPRAGUE DAWLEY RAT;

ANIMALS; BEHAVIOR, ANIMAL; CHOLESTASIS; INJECTIONS, INTRAVENTRICULAR; INTERLEUKIN-1; MALE; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; SICK ROLE;

EID: 0031593390     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510280616     Document Type: Article

References (29)

1. Kent S, Bluthé R-M, Kelley KW, Dantzer R. Sickness behaviour as a new target for drug development. Trends Pharmacol Sci 1992:13:24-28.
2. Hart BL. Biological basis of the behaviour of sick animals. Neurosci Biobehav Rev 1988;12:123-137.
3. Rothwell NJ, Hopkins SJ. Cytokines and the nervous system II: actions and mechanisms of action. Trends Neurol Sci 1995;8:130-136.
4. Otterness IG, Seymour PA, Golden HW, Reynolds JA, Daumy GO. The effects of continuous administration of murine interleukin-1α in the rat. Physiol Behav 1988;43:797-804.
5. Licinio J, Wong M-L. Perspectives series: cytokines and the brain. Pathways and mechanisms for cytokine signaling of the central nervous system. J Clin Invest 1997;100:2941-2947.
6. Segreti J, Gheusi G, Dantzer R, Kelley KW, Johnson RW. Defect in interleukin-1β secretion prevents sickness behaviour in C3H/HeJ mice. Physiol Behav 1997;61:873-878.
7. Kent S, Bluthe R-M, Dantzer R, Hardwick AJ, Kelley KW, Rothwell NJ, Vannice JL. Different receptor mecahnisms mediate the pyrogenic and behavioural effects of interleukin 1. Proc Natl Acad Sci U S A 1992;89:9117-9120.
8. Spadaro F, Dunn AJ. Intracerbroventricular administration of interleukin-1 to mice alters investigation of simuli in a novel environment. Brain Behav Immun 1990;4:308-322.
9. Banks WA, Ortiz L, Plotkin SR, Kastin AJ. Human interleukin (IL) 1 alpha, murine 1L-1 alpha and murine IL-1 beta are transported from blood to brain in the mouse by a shared saturable mechanism. J Pharmacol Exp 1991;259:988-996.
10. Schöbitz B, De Kloet ER, Holsboer F. Gene expression and function of interleukin 1, interleukin 6 and tumour necrosis factor in the brain. Prog Neurobiol 1994;44:397-432.
11. Hagan P, Poole S, Bristow AF. Endotoxin-stimulated production of rat hypothalamic interleukin-1β in vivo and in vitro, measured by specific immunoradiometric assay. J Mol Endocrinol 1993;11:31-36.
12. Van Dam A-M, Bauer J, Tilders FJH, Berkenbosch E Endotoxin-induced appearance of imunoreactive interleukin-1β in ramified microglia in rat brain: a light and electron microscopic study. Neuroscience 1995;65:815-826.
13. Jones EA. Fatigue associated with chronic liver disease: a riddle wrapped inside a mystery inside an enigma. HEPATOLOGY 1995;22:1606-1608.
14. Witt-Sullivan H, Heathcote J, Cauch K, Blendis L, Ghent C, Katz A, Milner R, et al. The demography of primary biliary cirrhosis in Ontario, Canada. HEPATOLOGY 1990;12:98-105.
15. Cameron GR, Oakley CL. Ligation of the common bile duct. J Pathol Bacteriol 1932;35:769-798.
16. Swain MG, Marie M. Imparted stress and interleukin-1β-induced hypothalamic expression of the neuronal activation marker FOS in cholestatic rats. HEPATOLOGY 1996;24:914-918.
17. Swain MG, Marie M. Defective corticotropin-releasing hormone mediated neuroendocrine and behavioural responses in cholestatic rats: implications for cholestatic liver disease-related sickness behaviours. HEPATOLOGY 1995;22:1560-1564.
18. Minami M, Kuraishi Y, Hamaguchi T, Nakai S, Hirai Y, Satoh M. Immobilization stress induces interleukin-1β mRNA in the rat hypothalamus. Neurosci Lett 1991;123:254-256.
19. Uehara A, Sekiya C, Takasugi Y, Namiki M, Arimura A. Anorexia induced by interleukin1: involvement of corticotropin-releasing hormone. Am J Physiol 1989;257:R613-R617.
20. Linthorst ACE, Flackskamm C, Müller-Preuss P, Holsboer F, Reul JMHM. Effect of bacterial endotoxin and interleukin-1β on hippocampal serotonergic neurotransmission, behavioural activity, and free corticosterone levels: an in vivo microdialysis study. J Neurosci 1995;15:2920-2934.
21. Lechan RM, Toni R, Clark BD, Cannon JG, Shaw AR, Dinarello CA, Reichlin S. Immunoreactive interleukin-1β localization in the rat forebrain. Brain Res 1990;514:135-140.
22. Dunn AJ, Anton M, Chapman Y. Reduction of exploratory behaviour by intraperitoneal injection of interleukin-1 involves brain corticotropin-releasing factor. Brain Res Bull 1990;26:539-542.
23. Swain MG, Patchev V, Vergalla J, Chrousos G, Jones EA. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis. J Clin Invest 1993;91:1903-1908.
24. Crestani F, Seguy F, Dantzer R. Behavioural effects of peripherally injected interleukin1: role of prostaglandins. Brain Res 1991;542:330-335.
25. 2 release. Am J Physiol 1995;268:G404-G409.
26. Pezeshki G, Pohl T, Schöbitz B. Corticosterone controls interleukin-1β expression and sickness behaviour in the rat. J Neuroendocrinol 1996;8:129-135.
27. Swain MG, Marie M. Prevention of immune-mediated arthritis in cholestatic rats: role of endogenous glucocorticoids. Gastroenterology 1994;107:1469-1474.
28. Bluthé R-M, Sparber S, Dantzer R. Modulation of the behavioural effects of interleukin-1 in mice by nitric oxide. NeuroReport 1991;3:207-209.
29. Swain MG, Le T, Tigley AW, Beck P. Hypothalamic nitric oxide synthase is depressed in cholestatic rats. Am J Physiol 1997;272:G1034-G1040.